絞り込み

16547

広告

Patient satisfaction after switching from warfarin to apixaban in patients with nonvalvular atrial fibrillation: AGAIN study.

著者 Koretsune Y , Ikeda T , Kozuma K , Hirano T , Yasaka M , Kida M , Chachin M , Imura M
Patient Prefer Adherence.2017 ; 11():1987-1996.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (70view , 0users)

Full Text Sources

Patients treated with warfarin must adhere to frequent monitoring, dietary restrictions, and complicated dose adjustments. Apixaban, a direct factor Xa inhibitor, is an alternative to warfarin that may reduce patient burdens associated with warfarin therapy. However, there is limited evidence pertaining to patient satisfaction with anticoagulant therapies in Japanese patients. The purpose of this observational study was to investigate changes in patient satisfaction after switching from warfarin to apixaban.
PMID: 29290682 [PubMed]
印刷用ページを開く Endnote用テキストダウンロード